Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study

被引:0
|
作者
Dryden, Murray [1 ]
Mudara, Caroline [1 ]
Vika, Caroline [1 ]
Blumberg, Lucille [1 ,3 ]
Mayet, Natalie [1 ]
Cohen, Cheryl [2 ,4 ]
Tempia, Stefano [2 ,4 ]
Parker, Arifa [8 ,9 ,10 ]
Nel, Jeremy [7 ]
Perumal, Rubeshan [11 ]
Groome, Michelle J. [1 ,5 ]
Conradie, Francesca [6 ]
Ndjeka, Norbert [12 ,13 ]
Sigfrid, Louise [14 ]
Merson, Laura [15 ]
Jassat, Waasila [1 ,3 ]
机构
[1] Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Div Natl Hlth Lab Serv, Johannesburg, South Africa
[2] Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Ctr Resp Dis & Meningitis, Johannesburg, South Africa
[3] Right Care, Centurion, South Africa
[4] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa
[5] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa
[6] Univ Witwatersrand, Fac Hlth Sci, Clin HIV Res Unit, Johannesburg, South Africa
[7] Univ Witwatersrand, Fac Hlth Sci, Dept Med, Div Infect Dis, Johannesburg, South Africa
[8] Stellenbosch Univ, Fac Med & Hlth Sci, Div Gen Med, Cape Town, South Africa
[9] Stellenbosch Univ, Fac Med & Hlth Sci, Div Infect Dis, Cape Town, South Africa
[10] Tygerberg Hosp, Cape Town, South Africa
[11] Univ KwaZulu Natal, South African Med Res Council, CAPRISA HIV TB Pathogenesis & Treatment Res Unit, Ctr AIDS Programme Res South Africa, Durban, South Africa
[12] Natl Dept Hlth, Drug Resistant TB TB & HIV Directorate, Pretoria, South Africa
[13] Univ KwaZulu Natal, Durban, South Africa
[14] Univ Oxford, Nuffield Dept Med, Int Severe Acute Resp & Emerging Infect Consortiu, Global Support Ctr, Oxford, England
[15] Univ Oxford, Nuffield Dept Med, Int Severe Acute Resp & Emerging Infect Consortiu, Pandem Sci Ctr, Oxford, England
来源
LANCET GLOBAL HEALTH | 2022年 / 10卷 / 09期
基金
比尔及梅琳达.盖茨基金会;
关键词
COVID-19; SURVIVORS;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Post COVID-19 condition (PCC), as defined by WHO, refers to a wide range of new, returning, or ongoing health problems in people who have had COVID-19, and it represents a rapidly emerging public health priority. We aimed to establish how this developing condition has affected patients in South Africa and which population groups are at risk. Methods In this prospective cohort study, we used the DATCOV national hospital surveillance system to identify participants aged 18 years or older who had been hospitalised with laboratory-confirmed SARS-CoV-2 infection in South Africa. Participants underwent telephone follow-up assessment at 1 month and 3 months after hospital discharge. Participants were assessed using a standardised questionnaire for the evaluation of symptoms, functional status, health-related quality of life, and occupational status. We used negative binomial regression models to determine factors associated with PCC. Findings Of 241 159 COVID-19 admissions reported to DATCOV between Dec 1, 2020, and Aug 23, 2021, 8309 were randomly selected for enrolment. Of the 3094 patients that we were able to contact, 2410 (77.9%) consented to participate in the study at 1 month after discharge. Of these, 1873 (77.7%) were followed up at 3 months after hospital discharge. Participants had a median age of 52 years (IQR 41-62) and 960 (51.3%) were women. At 3 months of follow-up, 1249 (66.7%) of 1873 participants reported new or persistent COVID-19-related symptoms, compared with 1978 (82.1%) of 2410 at 1 month after hospital discharge. The most common symptoms reported at 3 months were fatigue (50.3%), shortness of breath (23.4%), confusion or lack of concentration (17.5%), headaches (13 - 8%), and problems seeing or blurred vision (10.1%). On multivariable analysis, the factors associated with persistent symptoms after acute COVID-19 were being female (adjusted incident rate ratio 1.20, 95% CI 1. 04-1. 38) and admission to an intensive care unit (147, 1.01-1.37). Interpretation Most participants in this cohort of individuals previously hospitalised with COVID-19 reported persistent symptoms 3 months after hospital discharge and a significant impact of PCC on their functional and occupational status. The large burden of PCC symptoms identified in this study emphasises the need for a national health strategy. This should include the development of clinical guidelines and training of health-care workers for identifying, assessing, and caring for patients affected by PCC; establishment of multidisciplinary health services; and provision of information and support to people who have PCC. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.
引用
收藏
页码:E1247 / E1256
页数:10
相关论文
共 50 条
  • [1] Vaccination After SARS-CoV-2 Infection and Post-COVID-19 Condition
    Yang, Chengliang
    Lapp, Linda
    Tebbutt, Scott J.
    [J]. JAMA INTERNAL MEDICINE, 2023, 183 (09) : 1035 - 1036
  • [2] Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
    Goertz, Yvonne M. J.
    Van Herck, Maarten
    Delbressine, Jeannet M.
    Vaes, Anouk W.
    Meys, Roy
    Machado, Felipe V. C.
    Houben-Wilke, Sarah
    Burtin, Chris
    Posthuma, Rein
    Franssen, Frits M. E.
    van Loon, Nicole
    Hajian, Bita
    Spies, Yvonne
    Vijlbrief, Herman
    van't Hul, Alex J.
    Janssen, Daisy J. A.
    Spruit, Martijn A.
    [J]. ERJ OPEN RESEARCH, 2020, 6 (04) : 1 - 10
  • [3] Vaccination After SARS-CoV-2 Infection and Post-COVID-19 Condition-Reply
    Tsampasian, Vasiliki
    Vassiliou, Vassilios S.
    [J]. JAMA INTERNAL MEDICINE, 2023, 183 (09) : 1036 - 1036
  • [4] Complications Post-COVID-19 and Risk Factors among Patients after Six Months of a SARS-CoV-2 Infection: A Population-Based Prospective Cohort Study
    Domenech-Montoliu, Salvador
    Puig-Barbera, Joan
    Pac-Sa, Maria Rosario
    Vidal-Utrillas, Paula
    Latorre-Poveda, Marta
    Del Rio-Gonzalez, Alba
    Ferrando-Rubert, Sara
    Ferrer-Abad, Gema
    Sanchez-Urbano, Manuel
    Aparisi-Esteve, Laura
    Badenes-Marques, Gema
    Cervera-Ferrer, Belen
    Clerig-Arnau, Ursula
    Dols-Bernad, Claudia
    Fontal-Carcel, Maria
    Gomez-Lanas, Lorna
    Jovani-Sales, David
    Leon-Domingo, Maria Carmen
    Llopico-Vilanova, Maria Dolores
    Moros-Blasco, Mercedes
    Notari-Rodriguez, Cristina
    Ruiz-Puig, Raquel
    Valls-Lopez, Sonia
    Arnedo-Pena, Alberto
    [J]. EPIDEMIOLOGIA, 2022, 3 (01): : 49 - 67
  • [5] Post-COVID-19 syndrome/condition or long COVID Persistent illness after acute SARS-CoV-2 infection
    Allard, Nicole
    Miller, Alistair
    Morgan, Mark
    Chakraborty, Samantha
    [J]. AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2022, 51 (12) : 952 - 957
  • [6] SARS-CoV-2, aging, and Post-COVID-19 neurodegeneration
    Strong, Michael J.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2023, 165 (02) : 115 - 130
  • [7] Lower prevalence of post-Covid-19 Condition following Omicron SARS-CoV-2 infection
    de Bruijn, Simeon
    van Hoek, Albert Jan
    Mutubuki, Elizabeth N.
    Knoop, Hans
    Slootweg, Jaap
    Tulen, Anna D.
    Franz, Eelco
    van den Wijngaard, Cees C.
    van der Maaden, Tessa
    [J]. HELIYON, 2024, 10 (07)
  • [8] Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan
    Gu, Xiaoying
    Huang, Lixue
    Zhang, Hui
    Cao, Bin
    [J]. LANCET, 2024, 403 (10434): : 1336 - 1337
  • [9] Perceived Cognitive Deficits in Patients With Symptomatic SARS-CoV-2 and Their Association With Post-COVID-19 Condition
    Liu, Teresa C.
    Yoo, Sun M.
    Sim, Myung S.
    Motwani, Yash
    Viswanathan, Nisha
    Wenger, Neil S.
    [J]. JAMA NETWORK OPEN, 2023, 6 (05) : E2311974
  • [10] Multidimensional Sleep Health Prior to SARS-CoV-2 Infection and Risk of Post-COVID-19 Condition
    Wang, Siwen
    Huang, Tianyi
    Weisskopf, Marc G.
    Kang, Jae H.
    Chavarro, Jorge E.
    Roberts, Andrea L.
    [J]. JAMA NETWORK OPEN, 2023, 6 (05) : e2315885